Condition
Dementia, Mild
ClinicalTrials.gov condition label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 27 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
27 shownMazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)NCT07083154 · 2025-09-27
RECRUITINGPaper-Based and Smartphone-Based Memory SupportsNCT06444841 · 2024-06-27
RECRUITINGAutonomic Involvement in Patient With Cognitive DeclineNCT06292741 · 2023-01-11
RECRUITINGPUMCH Dementia Longitudinal Cohort StudyNCT05023564 · 2020-12-01
RECRUITINGTau PET Outcomes With Anti-amyloid ImmunotherapiesNCT06723015 · 2025-11-04
ENROLLING_BY_INVITATIONEffect of 10 mg Xanamem on Dementia Due to Alzheimer's DiseaseNCT06125951 · 2024-04-12
ACTIVE_NOT_RECRUITINGDecision Making Tool for Firearm StorageNCT06382194 · 2024-04-10
TERMINATEDExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)NCT06245031 · 2024-02-29
ENROLLING_BY_INVITATIONFamily Caregiver Online Survey (Dementia and Swallowing Difficulties)NCT06471660 · 2023-11-07
COMPLETEDFitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's DiseaseNCT05504811 · 2023-09-08
COMPLETEDPrecision Medicine Approach for Early Dementia & Mild Cognitive ImpairmentNCT05894954 · 2023-07-31
COMPLETEDCognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic TrialNCT05860127 · 2023-04-10
COMPLETEDEvent-Related Potential (ERP) Components in Clinical DiagnosisNCT05673759 · 2023-03-06
TERMINATEDA Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)NCT05637801 · 2022-12-13
COMPLETEDSTRATEGIES to Improve Memory in Alzheimer's DiseaseNCT04942184 · 2022-10-01
WITHDRAWNChocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged PeopleNCT05343611 · 2022-05-01
UNKNOWNCare Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and EmotionsNCT05165186 · 2022-04-13
UNKNOWNA Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's DiseaseNCT05328115 · 2021-09-30
COMPLETEDAdaptation of the Uniform Data Set for Telematic AdministrationNCT05785910 · 2021-09-14
COMPLETEDVirtual Individual Cognitive Stimulation Therapy: a Proof of Concept StudyNCT04828434 · 2021-04-01
UNKNOWNImproving Everyday Task Performance Through Repeated Practice in Virtual Reality.NCT04315337 · 2021-01-12
COMPLETEDImplementation of a Diagnostic Decision-aid for People With Memory Complaints and Their General PractitionersNCT04531956 · 2021-01-01
COMPLETEDFeasibility of the SmartPrompt for Improving Everyday Function in DementiaNCT04313582 · 2020-03-13
COMPLETEDStudy of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)NCT03661034 · 2018-05-31
UNKNOWNMulti-Center Study of Sensory Stimulation to Improve Brain FunctionNCT03556280 · 2018-04-24
ACTIVE_NOT_RECRUITINGComparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's DiseaseNCT03384043 · 2018-01-08
COMPLETEDNormative Values for the German Version of the Montreal Cognitive Assessment (MoCA)NCT03246269 · 2016-12-01
COMPLETEDCommon interventions
PlaceboDRUG218F-AV-1451DRUG1Additional neuropsychological testsBEHAVIORAL1ALZ-101BIOLOGICAL1Combination of High Protein Diet and Physical Exercise protocolBEHAVIORAL1Conventional exercise programOTHER1Decision aidOTHER1Diagnostic decision aid s-decidedOTHER1Digital - Google CalendarBEHAVIORAL1Electroencephalogram (EEG) headset in Arm 1DEVICE1Electroencephalogram (EEG) headset in Arm 2DEVICE1Electroencephalogram (EEG) systemDEVICE1FitMi ADDEVICE1GammaSense Stimulation System (Active Settings)DEVICE1GammaSense Stimulation System (non-invasive, non-significant risk)DEVICE1GammaSense Stimulation System (Sham Settings)DEVICE1Hormones and Medications tailored to lab tests, combined with devices that support stress management and brain exercisesCOMBINATION_PRODUCT1HPP ChokoDIETARY_SUPPLEMENT1HPP/VE ChokoDIETARY_SUPPLEMENT1Implementation IntentionBEHAVIORAL1IUDSDIAGNOSTIC_TEST1Lifestyle including diet, exercise, stress managementBEHAVIORAL1MazdutideDRUG1Memory strategies in Arm 1BEHAVIORAL1Memory strategies in Arm 2BEHAVIORAL1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Cognito Therapeutics, Inc.
4
Baylor University
2
Boston University
2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2
Temple University
2
Actinogen Medical
1
Alzheimer's Prevention and Reversal Project, Inc.
1
Alzinova AB
1
Andreas Monsch
1
Flint Rehabilitation Devices, LLC
1
Maastricht University
1
Massachusetts General Hospital
1
Massimo Venturelli, PhD
1
Mayo Clinic
1
Peking Union Medical College Hospital
1
Trial status mix
COMPLETED12
RECRUITING4
UNKNOWN4
ACTIVE_NOT_RECRUITING2
ENROLLING_BY_INVITATION2
TERMINATED2
WITHDRAWN1
Phase mix
NA18
PHASE33
PHASE22
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.